Protalex Announces Publication in the British Journal of Haematology Supporting the Potential of PRTX-100 to Treat Immune Thrombocytopenia
Wall Street Online Denmark,
Protalex, Inc. (OTCQB:PRTX), a clinical-stage biopharmaceutical company, announces that preclinical data showing its lead drug…